
https://www.facingourrisk.org/research-clinical-trials/study/317 /research-study-on-the-genetics-of-breast-cancer
Clinicaltrials.gov identifier:
NCT06773897 (https://clinicaltrials.gov/show/NCT06773897)
Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States
Study Contact Information:
PI: Dr. Tara Matise [email protected]
Researchers at Rutgers University are conducting a fully online study to better understand how genes affect your risk of breast cancer. Your participation can help researchers discover new genetic factors that improve risk prediction, prevention, and future treatment options.
While genes such as BRCA1 and BRCA2 are known genetic causes of breast cancer, they only explain about 25% of inherited genetic risk. Researchers believe many additional genetic variants remain undiscovered.
To make these discoveries, we need participants from all racial and ethnic backgrounds. A more diverse research community can lead to better science and improved care for everyone.
No office visit is required.
Join the Rutgers Breast Cancer Genetics Study: https://go.rutgers.edu/BCStudyFORCE
Participation is simple and takes approximately 20 minutes.
You'll:
There are no in-person visits required.
Participants will also receive monthly study updates and information about their genetic ancestry at no cost.
For genetic research to benefit everyone, it must include everyone.
Most genetic studies have focused on one group of people, limiting what researchers know about breast cancer risk in many other populations. Every participant helps make breast cancer research more representative of all communities, supporting better risk prediction, earlier prevention, and improved treatments for future generations.
Join the Rutgers Breast Cancer Genetics Study: https://go.rutgers.edu/BCStudyFORCE
Principal Investigator
Dr. Tara Matise
Department of Genetics
Rutgers University
Piscataway, NJ 08854
You may be eligible if you are:
You are not eligible if you are:
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.